Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Naltrexone for Painful Diabetic Neuropathy
NCT04678895Phase 2Recruiting
- Sponsor
- Dartmouth Health
- Start
- Dec 2020
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in diabetic neuropathy, sponsored by Dartmouth Health. Started Dec 2020; status: recruiting.
02
Drugs
naltrexone
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT04678895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04678895.